Obstructive Pulmonary Disease Global Clinical Trials Review Q1, 2011 Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011
Summary
GlobalData's clinical trial report, "Obstructive Pulmonary Disease Global Clinical Trials Review, Q1, 2011" provides data on the Obstructive Pulmonary Disease clinical trial... |
Respiration Disorders Global Clinical Trials Review Q1, 2011 Respiration Disorders Global Clinical Trials Review, Q1, 2011
Summary
GlobalData's clinical trial report, "Respiration Disorders Global Clinical Trials Review, Q1, 2011" provides data on the Respiration Disorders clinical trial scenario. This report... |
Generics in Japan Japan is the second largest pharmaceutical market in the world. But only 5% of the market, by value, is taken by generic drugs. Like other major industrialised nations... |
Bipolar Disorder This report analyzes the worldwide markets for Bipolar Disorder in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific and Rest of World. Annual estimates and... |
Dainippon Sumitomo Pharma Co., Ltd.-Therapeutic Competitors Report Dainippon Sumitomo Pharma Co., Ltd.-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with... |
Diabetic Neuropathy Global Clinical Trials Review Q2, 2011 Summary
GlobalData's clinical trial report, "Diabetic Neuropathy Global Clinical Trials Review, Q1, 2011" provides data on the Diabetic Neuropathy clinical trial scenario. This report provides elemental information and data relating to... |
Dainippon Sumitomo Pharma Co., Ltd.-Detailed Product Pipeline Dainippon Sumitomo Pharma Co., Ltd.-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed individual product records.
Scope of... |
CNS Therapeutics This report analyzes the worldwide markets for CNS Therapeutics in Millions of US$. The specific product Groups analyzed are Anti-Alzheimer's, Anti-Parkinson's, Anti-Epilepsy, Pain Management (includes Migraine, Nociceptive and neuropathic pain),... |
Overactive Bladder Global Clinical Trials Review Q2, 2011 Summary
GlobalData's clinical trial report, "Overactive Bladder Global Clinical Trials Review, Q2, 2011" provides data on the Overactive Bladder clinical trial scenario. This report provides elemental information and data relating to... |
Dainippon Sumitomo Pharma Co., Ltd.-Deals & Alliances Report Dainippon Sumitomo Pharma Co., Ltd.-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product,... |
Schizophrenia Pipeline Assessment and Market Forecast to 2017 Schizophrenia - Pipeline Assessment and Market Forecast to 2017
Summary
GlobalData, the industry analysis specialist, has released its new report, ""Schizophrenia - Pipeline Assessment and Market Forecasts to 2017"". The report is... |